Your browser doesn't support javascript.
loading
Trends in insurance coverage and treatment among persons with opioid use disorders following the Affordable Care Act.
Feder, Kenneth A; Mojtabai, Ramin; Krawczyk, Noa; Young, Andrea S; Kealhofer, Marc; Tormohlen, Kayla N; Crum, Rosa M.
Afiliação
  • Feder KA; Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, 624 North Broadway, Baltimore, MD 21205, United States. Electronic address: kfeder1@jhu.edu.
  • Mojtabai R; Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, 624 North Broadway, Baltimore, MD 21205, United States.
  • Krawczyk N; Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, 624 North Broadway, Baltimore, MD 21205, United States.
  • Young AS; Johns Hopkins Medicine, Department of Psychiatry, 733 N Broadway, Baltimore, MD 21205, United States.
  • Kealhofer M; Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, 624 North Broadway, Baltimore, MD 21205, United States.
  • Tormohlen KN; Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, 624 North Broadway, Baltimore, MD 21205, United States.
  • Crum RM; Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, 624 North Broadway, Baltimore, MD 21205, United States.
Drug Alcohol Depend ; 179: 271-274, 2017 10 01.
Article em En | MEDLINE | ID: mdl-28823834
ABSTRACT

PURPOSE:

This short communication examines the impact of the Patient Protection and Affordable Care Act (PPACA) on insurance coverage and substance use treatment access among persons with opioid use disorders.

METHODS:

Data came from the 2010-2015 National Surveys on Drug Use and Health. Among persons with heroin and opioid pain-reliever use disorders, measures of insurance coverage and treatment access were compared before and after the implementation of major PPACA provisions that expanded access to insurance in 2014.

RESULTS:

The prevalence of uninsured persons among those with heroin use disorders declined dramatically following PPACA implementation (OR 0.59, 95% CI 0.39-0.89), largely due to an increase in the prevalence of Medicaid coverage (OR 1.96, 95% CI 1.21-3.18). There was no evidence of an increase in the prevalence of treatment, but among persons who received treatment, there was an increase in the proportion whose treatment was paid for by insurance (OR 3.75, 95% CI 2.13-3.18). By contrast, there was no evidence the uninsured rate declined among persons with pain-reliever use disorders.

CONCLUSIONS:

The PPACA Medicaid expansion increased insurance coverage among persons with heroin use disorders, and likely plays an essential role in protecting the health and financial security of this high-risk group. More research is needed on the relationship between insurance acquisition and utilization of substance use treatment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pessoas sem Cobertura de Seguro de Saúde / Cobertura do Seguro / Patient Protection and Affordable Care Act / Seguro Saúde / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Drug Alcohol Depend Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pessoas sem Cobertura de Seguro de Saúde / Cobertura do Seguro / Patient Protection and Affordable Care Act / Seguro Saúde / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Drug Alcohol Depend Ano de publicação: 2017 Tipo de documento: Article